Hemostasis and Tissue Sealing Agents Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

According to Vision Research Reports, the global Hemostasis and Tissue Sealing Agents market size surpassed at US$ 5.3 Bn in 2019 and is expected to reach at a CAGR of 8.5% from 2020 to 2027.

The global Hemostasis and Tissue Sealing Agents market size is projected to surpass around US$ 10.5 billion by 2027, rise in demand for minimally invasive procedures and increase in global geriatric population are projected to drive the global hemostasis and tissue sealing agents market during the forecast period.

Overview

• Hemostats are surgical tools that can be used to control bleeding during surgery. Topical hemostat and tissue sealant products are rapidly replacing the conventional sutures for wound and incision closure.
• Hemostasis and sealing agents are widely used in health care settings, as these offer several advantages such as minimal incision, reduced operating time, reduced post-operative infection risks and others.
• North America dominated the global hemostasis and tissue sealing agents market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased demand for hemostasis and tissue sealing agents and new product launch are expected to drive the market in North America.
• Asia Pacific is likely to be a highly lucrative market for hemostasis and tissue sealing agents and it is expected to expand at a high CAGR during the forecast period

High cost and strict regulatory requirement to Hamper Market

Hemostat and tissue sealant products development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidences, well controlled investigations and documented case studies. Despite high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. Low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market.

Aging population increases the number of surgeries needing hemostat products boost market growth

Treatment services have become affordable due to improvement in health care policies in countries such as the U.S., Japan, the U.K. and China. This, in turn, has increased the life expectancy of the population. Consequently, rise in the geriatric population increases the number of surgical procedures that use adhesion barrier and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000.

The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostat, tissue sealant and adhesion barrier products and boosts market growth.

Rise in Demand for Minimally Invasive Procedures and Technological Advancement to Drive Market

• Introduction of novel hemostat and sealant products is driving demand globally. For instance, introduction of fibrin sealant products has expanded the application areas in drug delivery mechanism and adhesion prevention. Moreover, periodic launch of new products and regulatory approvals of new hemostat products fuels the growth of the market. For instance, in December 2019, Ethicon (Johnson and Johnson) launched VISTASEAL fibrin sealant (Human) to help surgeons manage bleeding during surgery.
• The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications and shorter recovery time.
• Such factors are anticipated to drive demand for hemostat and sealant products, which in turn would provide opportunities for companies operating in the global hemostat and sealant products market

Topical Hemostat Segment to Dominate Market

• Based on type, the global hemostasis and tissue sealing agents market has been divided into topical hemostat and adhesive and tissue sealing agents. The topical hemostat segment dominated the global hemostasis and tissue sealing agents market in 2018 and the trend is projected to continue during the forecast period. Topical hemostats play an important role to control bleeding in surgical procedures when ligatures or conventional procedures are ineffective or impractical. These products diffuse the surface bleeding, bone bleeding, venous bleeding, and reduce the post-operative complications during surgical procedures. Topical hemostats can be used in both intra-operative and post-operative procedures to arrest bleeding. Such factors are helps to drive the growth this segment during forecasted period.
• The topical hemostat segment further sub-segmented into mechanical hemostats, active hemostats and flowable hemostats. Mechanical hemostats includes collagen based topical hemostats, ORC based topical hemostats, gelatin based topical hemostats and polysaccharide based topical hemostats.
• Adhesive and tissue sealing agents segment divided into natural tissue sealant, synthetic tissue sealant and adhesion barrier products. Out of this natural tissue sealant segment dominate the global hemostasis and tissue sealing agents market in 2018. Natural tissue sealants consist of biological components such as cryoprecipitate and fibrin that stimulate the body’s natural clotting process. Such factor is likely to drive the growth of this segment.

North America to Dominate Global Market

• In terms of region, the global hemostasis and tissue sealing agents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global hemostasis and tissue sealing agents market in 2019, followed by Europe.
• North America accounted for major share of the global hemostasis and tissue sealing agents market in 2019. This is attributable to rising number of inpatient and outpatient surgical procedures in this region and prevalence of cardiovascular disorders, diabetes, and cancer within the region. Such factors are helps to increase the demand for hemostat products, thereby driving market growth.
• The hemostasis and tissue sealing agents market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to growing economies such as China, Japan, India, South Korea, and Singapore, and continuous rise in health care expenditure. In addition, increasing penetration by market players such as Ethicon, Inc., Integra LifeSciences Corporation, and CryoLife, Inc. in these geographies supports the growth of this market.

Competitive Landscape

• The global hemostasis and tissue sealing agents market is fragmented in terms of number of players. Key players in the global market include Advanced Medical Solutions Group plc, Baxter, Cohera Medical, Inc., CryoLife, Inc., C.R. Bard, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation, Pfizer, Inc., Cohesion Technologies Inc., B Braun Medical Inc. and other prominent players.

Market Segmentation

By Type

• Topical Hemostat
  • Mechanical Hemostats
    • Collagen based Topical Hemostats
    • ORC based Topical Hemostats
    • Gelatin based Topical Hemostats
  • Polysaccharide based Topical Hemostats
    • Active Hemostats
    • Flowable Hemostats
•  Adhesive and Tissue Sealing Agents
  • Natural Tissue Sealant
  • Synthetic Tissue Sealant
  • Adhesion Barrier Products

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific          
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global hemostasis and tissue sealing agents market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global hemostasis and tissue sealing agents market for the period 2017–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hemostasis and tissue sealing agents market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hemostasis and tissue sealing agents market.

Secondary research also included internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global hemostasis and tissue sealing agents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hemostasis and tissue sealing agents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hemostasis and tissue sealing agents market.

The report delves into the competitive landscape of the global hemostasis and tissue sealing agents market. Key players operating in the global hemostasis and tissue sealing agents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hemostasis and tissue sealing agents market that have been profiled in this report.

Key Questions Answered in Global Hemostasis and Tissue Sealing Agents Market Report

• What is the scope of growth of product companies in the global hemostasis and tissue sealing agents market?
• What will be the Y-o-Y growth of the global hemostasis and tissue sealing agents market between 2019 and 2027?
• What is the influence of changing trends in technologies on the global hemostasis and tissue sealing agents market?
• Will North America continue to be the most profitable market for hemostasis and tissue sealing agents providers?
• Which factors are anticipated to hamper the growth of the global hemostasis and tissue sealing agents market during the forecast period?
• Which are the leading companies in the global hemostasis and tissue sealing agents market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global hemostasis and tissue sealing agents market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global hemostasis and tissue sealing agents Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the hemostasis and tissue sealing agents market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hemostasis and tissue sealing agents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hemostasis and tissue sealing agents market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global hemostasis and tissue sealing agents market more reliably and accurately.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemostasis and Tissue Sealing Agents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Development in the Market

    5.2. Mergers & Acquisitions

    5.3. COVID-19 Impact Analysis

6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Type, 2017–2027

        6.2.1. Topical Hemostat

            6.2.1.1. Mechanical Hemostats

                6.2.1.1.1. Collagen based Topical Hemostats

                6.2.1.1.2. ORC based Topical Hemostats

                6.2.1.1.3. Gelatin based Topical Hemostats

                6.2.1.1.4. Polysaccharide based Topical Hemostats

            6.2.1.2. Active Hemostats

            6.2.1.3. Flowable Hemostats

        6.2.2.  Adhesive and Tissue Sealing Agents

            6.2.2.1. Natural Tissue Sealant

            6.2.2.2. Synthetic Tissue Sealant

            6.2.2.3. Adhesion Barrier Products

    6.3. Global Hemostasis and Tissue Sealing Agents Market Analysis, by Type

    6.4. Global Hemostasis and Tissue Sealing Agents Market Attractiveness, by Type

7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Region

        7.2.1. North America

        7.2.2. Europe

        7.2.3. Asia Pacific

        7.2.4. Latin America

        7.2.5. Middle East & Africa

    7.3. North America Hemostasis and Tissue Sealing Agents Market Attractiveness, by Region

8. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        8.2.1. Topical Hemostat

            8.2.1.1. Mechanical Hemostats

                8.2.1.1.1. Collagen based Topical Hemostats

                8.2.1.1.2. ORC based Topical Hemostats

                8.2.1.1.3. Gelatin based Topical Hemostats

                8.2.1.1.4. Polysaccharide based Topical Hemostats

            8.2.1.2. Active Hemostats

            8.2.1.3. Flowable Hemostats

        8.2.2.  Adhesive and Tissue Sealing Agents

            8.2.2.1. Natural Tissue Sealant

            8.2.2.2. Synthetic Tissue Sealant

            8.2.2.3. Adhesion Barrier Products

    8.3. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country, 2017–2027

        8.3.1. U.S.

        8.3.2. Canada

    8.4. North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        8.4.1. By Type

        8.4.2. By Country

9. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        9.2.1. Topical Hemostat

            9.2.1.1. Mechanical Hemostats

                9.2.1.1.1. Collagen based Topical Hemostats

                9.2.1.1.2. ORC based Topical Hemostats

                9.2.1.1.3. Gelatin based Topical Hemostats

                9.2.1.1.4. Polysaccharide based Topical Hemostats

            9.2.1.2. Active Hemostats

            9.2.1.3. Flowable Hemostats

        9.2.2.  Adhesive and Tissue Sealing Agents

            9.2.2.1. Natural Tissue Sealant

            9.2.2.2. Synthetic Tissue Sealant

            9.2.2.3. Adhesion Barrier Products

    9.3. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        9.4.1. By Type

        9.4.2. By Country/Sub-region

10. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.2.1. Topical Hemostat

            10.2.1.1. Mechanical Hemostats

                10.2.1.1.1. Collagen based Topical Hemostats

                10.2.1.1.2. ORC based Topical Hemostats

                10.2.1.1.3. Gelatin based Topical Hemostats

                10.2.1.1.4. Polysaccharide based Topical Hemostats

            10.2.1.2. Active Hemostats

            10.2.1.3. Flowable Hemostats

        10.2.2.  Adhesive and Tissue Sealing Agents

            10.2.2.1. Natural Tissue Sealant

            10.2.2.2. Synthetic Tissue Sealant

            10.2.2.3. Adhesion Barrier Products

    10.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        10.4.1. By Type

        10.4.2. By Country/Sub-region

11. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.2.1. Topical Hemostat

            11.2.1.1. Mechanical Hemostats

                11.2.1.1.1. Collagen based Topical Hemostats

                11.2.1.1.2. ORC based Topical Hemostats

                11.2.1.1.3. Gelatin based Topical Hemostats

                11.2.1.1.4. Polysaccharide based Topical Hemostats

            11.2.1.2. Active Hemostats

            11.2.1.3. Flowable Hemostats

        11.2.2.  Adhesive and Tissue Sealing Agents

            11.2.2.1. Natural Tissue Sealant

            11.2.2.2. Synthetic Tissue Sealant

            11.2.2.3. Adhesion Barrier Products

    11.3. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America Latin America

    11.4. Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        11.4.1. By Type

        11.4.2. By Country/Sub-region

12. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.2.1. Topical Hemostat

            12.2.1.1. Mechanical Hemostats

                12.2.1.1.1. Collagen based Topical Hemostats

                12.2.1.1.2. ORC based Topical Hemostats

                12.2.1.1.3. Gelatin based Topical Hemostats

                12.2.1.1.4. Polysaccharide based Topical Hemostats

            12.2.1.2. Active Hemostats

            12.2.1.3. Flowable Hemostats

        12.2.2.  Adhesive and Tissue Sealing Agents

            12.2.2.1. Natural Tissue Sealant

            12.2.2.2. Synthetic Tissue Sealant

            12.2.2.3. Adhesion Barrier Products

    12.3. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        12.4.1. By Application

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by Tier and Size of companies)

    13.2. Market Share / Position Analysis, by Company, 2019

    13.3. Company Profiles

        13.3.1. Advanced Medical Solutions Group plc  

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Financial Analysis

            13.3.1.3. Growth Strategies

            13.3.1.4. SWOT Analysis

        13.3.2. Baxter

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Financial Analysis

            13.3.2.3. Growth Strategies

            13.3.2.4. SWOT Analysis

        13.3.3. Cohera Medical, Inc .

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Financial Analysis

            13.3.3.3. Growth Strategies

            13.3.3.4. SWOT Analysis

        13.3.4. CryoLife, Inc .

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Financial Analysis

            13.3.4.3. Growth Strategies

            13.3.4.4. SWOT Analysis

        13.3.5. C.R. Bard, Inc  

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Financial Analysis

            13.3.5.3. Growth Strategies

            13.3.5.4. SWOT Analysis

        13.3.6. Johnson & Johnson Services, Inc  

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Financial Analysis

            13.3.6.3. Growth Strategies

            13.3.6.4. SWOT Analysis

        13.3.7. Integra LifeSciences Corporation.

            13.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Financial Analysis

            13.3.7.3. Growth Strategies

            13.3.7.4. SWOT Analysis

        13.3.8. Pfizer, Inc.  

            13.3.8.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Financial Analysis

            13.3.8.3. Growth Strategies

            13.3.8.4. SWOT Analysis

        13.3.9. Cohesion Technologies Inc.  

            13.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Financial Analysis

            13.3.9.3. Growth Strategies

            13.3.9.4. SWOT Analysis

        13.3.10. B Braun Medical Inc.  

            13.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Financial Analysis

            13.3.10.3. Growth Strategies

            13.3.10.4. SWOT Analysis

        13.3.11. Other prominent Players